Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Hypothalamic and brainstem glucose-dependent insulinotropic polypeptide receptor neurons employ distinct mechanisms to affect feeding
Alice E. Adriaenssens, Johannes Broichhagen, Anne de Bray, et al.
JCI Insight (2023) Vol. 8, Iss. 10
Open Access | Times Cited: 30

Showing 1-25 of 30 citing articles:

Dissociable hindbrain GLP1R circuits for satiety and aversion
Kuei-Pin Huang, Alisha A Acosta, Misgana Y. Ghidewon, et al.
Nature (2024) Vol. 632, Iss. 8025, pp. 585-593
Closed Access | Times Cited: 34
Transforming obesity: The advancement of multi-receptor drugs
Christine M. Kusminski, Diego Pérez–Tilve, Timo D. Müller, et al.
Cell (2024) Vol. 187, Iss. 15, pp. 3829-3853
Closed Access | Times Cited: 24
Glucose-dependent insulinotropic polypeptide (GIP)
Timo D. Müller, Alice E. Adriaenssens, Bo Ahrén, et al.
Molecular Metabolism (2025) Vol. 95, pp. 102118-102118
Open Access | Times Cited: 2
Glucose-dependent insulinotropic polypeptide regulates body weight and food intake via GABAergic neurons in mice
Arkadiusz Liśkiewicz, Ahmed Khalil, Daniela Liśkiewicz, et al.
Nature Metabolism (2023) Vol. 5, Iss. 12, pp. 2075-2085
Open Access | Times Cited: 36
The Road towards Triple Agonists: Glucagon-Like Peptide 1, Glucose-Dependent Insulinotropic Polypeptide and Glucagon Receptor - An Update
Agnieszka Jakubowska, Carel W. le Roux, Adie Viljoen
Endocrinology and Metabolism (2024) Vol. 39, Iss. 1, pp. 12-22
Open Access | Times Cited: 15
GLP1R and GIPR expression and signaling in pancreatic alpha cells, beta cells and delta cells
Ali H. Shilleh, Katrina Viloria, Johannes Broichhagen, et al.
Peptides (2024) Vol. 175, pp. 171179-171179
Open Access | Times Cited: 11
Brain access of incretins and incretin receptor agonists to their central targets relevant for appetite suppression and weight loss
Sophie Buller, Clémence Blouet
AJP Endocrinology and Metabolism (2024) Vol. 326, Iss. 4, pp. E472-E480
Open Access | Times Cited: 10
Stimulating intestinal GIP release reduces food intake and body weight in mice
Jo E. Lewis, Danaé Nuzzaci, Paula-Peace James-Okoro, et al.
Molecular Metabolism (2024) Vol. 84, pp. 101945-101945
Open Access | Times Cited: 10
Pharmacological Advances in Incretin-Based Polyagonism: What We Know and What We Don’t
Aaron Novikoff, Timo D. Müller
Physiology (2024) Vol. 39, Iss. 3, pp. 142-156
Closed Access | Times Cited: 6
Neuroendocrine gut–brain signaling in obesity
Tim Gruber, Franziska Lechner, Jean‐Philippe Krieger, et al.
Trends in Endocrinology and Metabolism (2024)
Open Access | Times Cited: 6
The antiemetic actions of GIP receptor agonism
Tito Borner, Bart C. De Jonghe, Matthew R. Hayes
AJP Endocrinology and Metabolism (2024) Vol. 326, Iss. 4, pp. E528-E536
Closed Access | Times Cited: 5
Regulation of energy metabolism through central GIPR signaling
Arkadiusz Liśkiewicz, Timo D. Müller
Peptides (2024) Vol. 176, pp. 171198-171198
Open Access | Times Cited: 5
The physiological impact of an N‐terminal Halo‐tag on glucose‐dependent insulinotropic polypeptide receptor function in mice
Iona Davies, Yusman Manchanda, Kyle W. Sloop, et al.
Diabetes Obesity and Metabolism (2025)
Open Access
The role of GIPR in food intake control
Paula-Peace James-Okoro, Jo E. Lewis, Fiona M. Gribble, et al.
Frontiers in Endocrinology (2025) Vol. 16
Open Access
Incretin-based therapeutics for the treatment of neurodegenerative diseases
Anika Vear, Michael T. Heneka, Christoffer Clemmensen
Nature Metabolism (2025)
Closed Access
Interoceptive processing in the nucleus of the solitary tract
Tracy Huang, Shiqi Wang, Ran Chen
Current Opinion in Neurobiology (2025) Vol. 93, pp. 103021-103021
Open Access
GIPR-Ab/GLP-1 peptide–antibody conjugate requires brain GIPR and GLP-1R for additive weight loss in obese mice
Clarissa M. Liu, Elizabeth A. Killion, Rola Hammoud, et al.
Nature Metabolism (2025)
Open Access
GIPR agonism and antagonism decrease body weight and food intake via different mechanisms in male mice
Robert M. Gutgesell, Ahmed Khalil, Arkadiusz Liśkiewicz, et al.
Nature Metabolism (2025)
Open Access
Loss of GIPR in LEPR cells impairs glucose control by GIP and GIP:GLP-1 co-agonism without affecting body weight and food intake in mice
Seun Akindehin, Arkadiusz Liśkiewicz, Daniela Liśkiewicz, et al.
Molecular Metabolism (2024) Vol. 83, pp. 101915-101915
Open Access | Times Cited: 3
Incretin hormones and pharmacomimetics rapidly inhibit AgRP neuron activity to suppress appetite
Hayley E. McMorrow, Carolyn M. Lorch, Nikolas W. Hayes, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access | Times Cited: 3
Unraveling the impaired incretin effect in obesity and type 2 diabetes: Key role of hyperglycemia-induced unscheduled glycolysis and glycolytic overload
Naila Rabbani, Paul J. Thornalley
Diabetes Research and Clinical Practice (2024), pp. 111905-111905
Open Access | Times Cited: 3
The unexpected role of GIP in transforming obesity treatment
Inuk Zandvakili, Diego Pérez–Tilve
Trends in Endocrinology and Metabolism (2024)
Closed Access | Times Cited: 2
Specific loss of GIPR signaling in GABAergic neurons enhances GLP-1R agonist-induced body weight loss
Jordan Wean, Allison H. Kowalsky, Rhianna C. Laker, et al.
Molecular Metabolism (2024), pp. 102074-102074
Open Access | Times Cited: 2
Targeting central pathway of Glucose‐Dependent Insulinotropic Polypeptide, Glucagon and Glucagon‐like Peptide‐1 for metabolic regulation in obesity and type 2 diabetes
Zhimin Xu, Song Wen, Meiyuan Dong, et al.
Diabetes Obesity and Metabolism (2024)
Closed Access | Times Cited: 2
Does GIPR blockade as well as agonism have a role to play in management of obesity and diabetes?
Ryan A. Lafferty, Peter R. Flatt, Victor A. Gault, et al.
Journal of Endocrinology (2024) Vol. 262, Iss. 2
Open Access | Times Cited: 1
Page 1 - Next Page

Scroll to top